These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8317861)

  • 1. [Screening of deafness in the young child. Value, techniques and initial results of products of acoustic distortion].
    Bonfils P; Avan P; François M; Loundon N; Elbez M; Trotoux J; Narcy P
    Ann Otolaryngol Chir Cervicofac; 1993; 110(1):3-8; discussion 8-9. PubMed ID: 8317861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Products of acoustic distortion in the examination of deafness in an infant].
    Molini E; Ricci G; Simoncelli C; Capolunghi B; Alunni N; Pasquarella G; Crescenzi CL; Brunelli B
    Rev Laryngol Otol Rhinol (Bord); 1996; 117(5):393-8. PubMed ID: 9183914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neonatal screening of deafness: evoked otoacoustic emissions or acoustic distortion products?].
    Roman S; Mondain M; Triglia JM; Uziel A
    Rev Laryngol Otol Rhinol (Bord); 2001; 122(3):155-8. PubMed ID: 11799854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distortion-product otoacoustic emissions. Values for clinical use.
    Bonfils P; Avan P
    Arch Otolaryngol Head Neck Surg; 1992 Oct; 118(10):1069-76. PubMed ID: 1389058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distortion-product otoacoustic emission: early detection in deferoxamine induced ototoxicity.
    Delehaye E; Capobianco S; Bertetto IB; Meloni F
    Auris Nasus Larynx; 2008 Jun; 35(2):198-202. PubMed ID: 17869044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Otoacoustic distortion products in adults with normal hearing].
    Simoncelli C; Molini E; Ricci G; Capolunghi B; Alunni N
    Acta Otorhinolaryngol Ital; 1995 Apr; 15(2):80-6. PubMed ID: 8928654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of treatment with vincristine on transient evoked and distortion product otoacoustic emissions.
    Riga M; Psarommatis I; Korres S; Lyra Ch; Papadeas E; Varvutsi M; Ferekidis E; Apostolopoulos N
    Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1003-8. PubMed ID: 16359737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
    Knight KR; Kraemer DF; Winter C; Neuwelt EA
    J Clin Oncol; 2007 Apr; 25(10):1190-5. PubMed ID: 17401008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distortion-product otoacoustic emissions in neonates: normative data.
    Bonfils P; Avan P; Francois M; Trotoux J; Narcy P
    Acta Otolaryngol; 1992 Sep; 112(5):739-44. PubMed ID: 1456027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An alternative strategy for universal infant hearing screening in tertiary hospitals with a high delivery rate, within a developing country, using transient evoked oto-acoustic emissions and brainstem evoked response audiometry.
    Mathur NN; Dhawan R
    J Laryngol Otol; 2007 Jul; 121(7):639-43. PubMed ID: 17112395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Otoacoustic emissions: an emerging diagnostic tool.
    Noel PE; Ramsey MJ; Amedee RG
    J La State Med Soc; 1995 Apr; 147(4):125-30. PubMed ID: 7775838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acoustic distorsion products. A systematic analysis of technical parameters. How to explain the results?].
    Avan P; Bonfils P; Paoli C; Gallas D; Cymes M; Nores JM; Trotoux J
    Ann Otolaryngol Chir Cervicofac; 1992; 109(8):428-33. PubMed ID: 1304103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of high-risk infants using distortion product otoacoustic emissions.
    Bowes M; Smith C; Tan AK; Varette-Cerre P
    J Otolaryngol; 1999 Aug; 28(4):181-4. PubMed ID: 10461253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
    Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
    Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous otoacoustic emissions in neonates and effect of contralateral white noise stimulation.
    Franz B; Altidis P; Altidis B
    Int Tinnitus J; 2000; 6(2):168-71. PubMed ID: 14689637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient evoked otoacoustic emission latency and estimates of cochlear tuning in preterm neonates.
    Moleti A; Sisto R; Paglialonga A; Sibella F; Anteunis L; Parazzini M; Tognola G
    J Acoust Soc Am; 2008 Nov; 124(5):2984-94. PubMed ID: 19045786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between auditory threshold and transitory evoked otoacoustic emissions].
    Komazec Z; Milosević D; Mocko M; Dankuc D; Vlaski L
    Srp Arh Celok Lek; 2002; 130 Suppl 1():8-11. PubMed ID: 12395455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of cochlear function with distortion products of otoacoustic emissions in acoustic neuroma].
    Oeken J
    HNO; 1996 Dec; 44(12):677-84. PubMed ID: 9081952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.